StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
PURETROP.BO$159.60-0.09%
Fair $159.60+0.0%

PURETROP.BO

Puretrop Fruits Limited

Consumer Defensive / Food DistributionBSE

$159.60

-0.15 (-0.09%)

Fairly Valued+0.0%Fair Value $159.60Fund rank 34/100 · Data gapFallback financials|
SA 50/C
F-Score: 5/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 25% · confianza 25%

FCF escenarios

weak_data · normalized FCF $232.1M · quality 63.3/100

Data gap 34/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 54/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

50/100

C

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · PURETROP.BOLocal privado en este navegador · Puretrop Fruits Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$1.1B

P/E

17.5x

↑

EV/EBITDA

8.2x

↓

ROE

18.3%

↑

Gross Margin

37.2%

↑

Debt/Equity

0.01

↓
52-Week Range$160
$107$200

TradingView lightweight chart

PURETROP.BO price, volumen y niveles de valoración

Último $159.60Periodo +13200.0%
Fair value: $159.60

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

+4.7%

FCF CAGR

+40.4%

FCF margin

19.0%

FCF / Net income

0.92x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $1.22B · net income $252.9M · FCF $232.1M

2023-FY → 2026-FY

Gross margin

37.2%+1.0% pts

Operating margin

5.2%+0.0% pts

Net margin

20.7%+12.8% pts

FCF margin

19.0%+11.1% pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue$1.22B$1.22B$1.12B$1.05B$1.06B
Net Income$252.9M$252.9M$118.7M$599.5M$84.6M
EBITDA$155.6M$155.6M$-33.2M$-7.6M$108.1M
EPS——14.8960.598.03
Gross Margin37.2%37.2%24.3%24.2%36.2%
Operating Margin5.2%5.2%-9.5%-8.1%5.2%
Net Margin20.7%20.7%10.6%57.0%8.0%
Balance Sheet
Debt/Equity0.010.010.030.040.26
Current Ratio10.2110.21———
Cash Flow
Free Cash Flow$232.1M$232.1M$201.3M$664.2M$83.8M
Returns
ROE18.3%18.3%10.5%42.2%10.3%
Valuation
P/E17.5217.527.532.6712.88
EV/EBITDA8.248.24——11.70
P/B0.920.920.791.131.32
Growth & Yield
Revenue Growth9.1%9.1%6.2%-0.9%—
EPS Growth——-75.4%654.5%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +21.0%

Total return

+21.0%

Start / end P/E

n/dx → n/dx

EPS bridge

14.89 → n/d

Residual

+21.0%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+21.0%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.